EP.06.41 CD200 as a Novel Prognostic Biomarker in Early-Stage Lung Adenocarcinoma Immune Microenvironment
Back to course
Asset Subtitle
Luning Mao
Meta Tag
Speaker Luning Mao
Topic Pathology and Biomarkers
Powered By